| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |